Improvement of intestinal absorption of human calcitonin by chemical modification with fatty acids: Synergistic effects of acylation and absorption enhancers

被引:33
作者
Fujita, T
Fujita, T
Morikawa, K
Tanaka, H
Iemura, O
Yamamoto, A
Muranishi, S
机构
[1] Department of Biopharmaceutics, Kyoto Pharmaceutical University, Kyoto 607, Misasagi, Yamashina-ku
关键词
acylation; acetylated human calcitonin; caproylated human calcitonin; intestinal absorption; chemical modification; peptide delivery;
D O I
10.1016/0378-5173(95)04395-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To improve the intestinal absorption of human calcitonin (hCT), novel lipophilic derivatives of hCT were synthesized by chemical modification with short-chain length fatty acids such as acetic acid and caproic acid, and the intestinal absorption and stability of these derivatives were examined in rats. The intestinal absorption properties of hCT and its acyl derivatives, acetylated hCT (Ac-hCT) and caproylated hCT (Cap-hCT), were estimated by measuring its hypocalcemic effects. Their intestinal absorption and stability in the intestinal mucosal homogenates were improved by increasing the carbon number of the fatty acid. Furthermore, we investigated the effects of co-administered absorption enhancers, sodium glycocholate (Na-GC), N-lauryl-beta-D-maltoside (LM), sodium deoxycholate (Na-DC) and sodium salicylate (Na-Sal), on the intestinal absorption of hCT and its acyl derivatives. Their intestinal absorption was slightly enhanced by the addition of various absorption enhancers except for Na-Sal. However, the extent of the promoting effect was a little higher for a native hCT rather than for acyl-hCT derivatives. These results suggested that it may be possible to achieve the further absorption enhancement of hCT by using a combination of acylation and absorption enhancers.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 40 条
[1]   STABILITY OF ACYL DERIVATIVES OF INSULIN IN THE SMALL-INTESTINE - RELATIVE IMPORTANCE OF INSULIN ASSOCIATION CHARACTERISTICS IN AQUEOUS-SOLUTION [J].
ASADA, H ;
DOUEN, T ;
MIZOKOSHI, Y ;
FUJITA, T ;
MURAKAMI, M ;
YAMAMOTO, A ;
MURANISHI, S .
PHARMACEUTICAL RESEARCH, 1994, 11 (08) :1115-1120
[2]   ABSORPTION CHARACTERISTICS OF CHEMICALLY MODIFIED-INSULIN DERIVATIVES WITH VARIOUS FATTY-ACIDS IN THE SMALL AND LARGE-INTESTINE [J].
ASADA, H ;
DOUEN, T ;
WAKI, M ;
ADACHI, S ;
FUJITA, T ;
YAMAMATO, A ;
MURANISHI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :682-687
[3]   PRODRUGS OF PEPTIDES .6. BIOREVERSIBLE DERIVATIVES OF THYROTROPIN-RELEASING-HORMONE (TRH) WITH INCREASED LIPOPHILICITY AND RESISTANCE TO CLEAVAGE BY THE TRH-SPECIFIC SERUM ENZYME [J].
BUNDGAARD, H ;
MOSS, J .
PHARMACEUTICAL RESEARCH, 1990, 7 (09) :885-892
[4]   CONTROL OF IN-VIVO FATE OF ALBUMIN DERIVATIVES UTILIZING COMBINED CHEMICAL MODIFICATION [J].
FUJITA, T ;
NISHIKAWA, M ;
OHTSUBO, Y ;
OHNO, J ;
TAKAKURA, Y ;
SEZAKI, H ;
HASHIDA, M .
JOURNAL OF DRUG TARGETING, 1994, 2 (02) :157-165
[5]  
FUJITA T, 1990, J CONTROL RELEASE, V11, P149
[6]  
FUJITA T, 1992, J PHARMACOL EXP THER, V263, P971
[7]  
GINSBURG A, 1960, J BIOL CHEM, V235, P108
[8]   NASAL ABSORPTION OF INSULIN - ENHANCEMENT BY HYDROPHOBIC BILE-SALTS [J].
GORDON, GS ;
MOSES, AC ;
SILVER, RD ;
FLIER, JS ;
CAREY, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7419-7423
[9]  
HAGA M, 1990, CHEM PHARM BULL, V38, P1983, DOI 10.1248/cpb.38.1983
[10]  
HASHIDA N, 1984, J PHARMACOBIO-DYNAM, V7, P193